These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9566020)

  • 1. Esculentoside A inhibits tumor necrosis factor, interleukin-1, and interleukin-6 production induced by lipopolysaccharide in mice.
    Ju DW; Zheng QY; Cao X; Fang J; Wang HB
    Pharmacology; 1998 Apr; 56(4):187-95. PubMed ID: 9566020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esculentoside A suppresses lipopolysaccharide-induced pro-inflammatory molecule production partially by casein kinase 2.
    Li Y; Cao Y; Xu J; Qiu L; Xu W; Li J; Song Y; Lu B; Hu Z; Zhang J
    J Ethnopharmacol; 2017 Feb; 198():15-23. PubMed ID: 28027904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibitory effects of esculentoside A on mouse macrophages and antibody production].
    Ju DW; Zheng QY; Wang HB; Guan XJ; Fang J; Yi YH
    Yao Xue Xue Bao; 1994; 29(4):252-5. PubMed ID: 7976339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esculentoside A inhibits LPS-induced acute kidney injury by activating PPAR-γ.
    Chen DZ; Chen LQ; Lin MX; Gong YQ; Ying BY; Wei DZ
    Microb Pathog; 2017 Sep; 110():208-213. PubMed ID: 28666844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of esculentoside H on release of tumor necrosis factor from mouse peritoneal macrophages.
    Hu ZL; Zhang JP; Yi YH; Qian DH
    Zhongguo Yao Li Xue Bao; 1993 Nov; 14(6):550-2. PubMed ID: 8010057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of esculentoside A on production of interleukin-1, 2, and prostaglandin E2.
    Xiao ZY; Zheng QY; Jiang YY; Zhou B; Yin M; Wang HB; Zhang JP
    Acta Pharmacol Sin; 2004 Jun; 25(6):817-21. PubMed ID: 15169638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of esculentoside A on lipopolysaccharide-induced acute lung injury in mice.
    Zhong WT; Jiang LX; Wei JY; Qiao AN; Wei MM; Soromou LW; Xie XX; Zhou X; Ci XX; Wang DC
    J Surg Res; 2013 Nov; 185(1):364-72. PubMed ID: 23764313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibitory effect of esculentoside A on platelet activating factor released from calcimycin induced rat peritoneal macrophages].
    Fang J; Zheng QY
    Yao Xue Xue Bao; 1991; 26(10):721-4. PubMed ID: 1823713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nodakenin suppresses lipopolysaccharide-induced inflammatory responses in macrophage cells by inhibiting tumor necrosis factor receptor-associated factor 6 and nuclear factor-κB pathways and protects mice from lethal endotoxin shock.
    Rim HK; Cho W; Sung SH; Lee KT
    J Pharmacol Exp Ther; 2012 Sep; 342(3):654-64. PubMed ID: 22637723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esculentoside A specifically binds to ribosomal protein S3a and impairs LPS-induced signaling in macrophages.
    Li YH; Wang J; Liu Y; Qiu L; Li JZ; Hu HG; Hu ZL; Zhang W; Lu B; Zhang JP
    Int Immunopharmacol; 2018 Jan; 54():254-260. PubMed ID: 29169044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Esculentoside A inhibits LPS-induced BV2 microglia activation through activating PPAR-γ.
    Li-Hua D; Yan L; Shi-Ji W; Guang W; Lu-Lu S; Xue-Feng P; Pengda S
    Eur J Pharmacol; 2017 Oct; 813():61-65. PubMed ID: 28733218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protective effect of Esculentoside A on experimental acute liver injury in mice.
    Zhang F; Wang X; Qiu X; Wang J; Fang H; Wang Z; Sun Y; Xia Z
    PLoS One; 2014; 9(11):e113107. PubMed ID: 25405982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kalopanaxsaponin B inhibits LPS-induced inflammation by inhibiting IRAK1 Kinase.
    Joh EH; Jeong JJ; Kim DH
    Cell Immunol; 2012 Sep; 279(1):103-8. PubMed ID: 23117333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chikusetsusaponin IVa Methyl Ester Isolated from the Roots of Achyranthes japonica Suppresses LPS-Induced iNOS, TNF-α, IL-6, and IL-1β Expression by NF-κB and AP-1 Inactivation.
    Lee HJ; Shin JS; Lee WS; Shim HY; Park JM; Jang DS; Lee KT
    Biol Pharm Bull; 2016; 39(5):657-64. PubMed ID: 27150139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of tumor necrosis factor and subsequent endotoxin shock by pirfenidone.
    Cain WC; Stuart RW; Lefkowitz DL; Starnes JD; Margolin S; Lefkowitz SS
    Int J Immunopharmacol; 1998 Dec; 20(12):685-95. PubMed ID: 9877280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral IL-10 gene therapy inhibits TNF-alpha and IL-1 beta, not IL-6, in the newborn endotoxemic mouse.
    Drazan KE; Wu L; Bullington D; Shaked A
    J Pediatr Surg; 1996 Mar; 31(3):411-4. PubMed ID: 8708914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo inhibition of endotoxin-induced pro-inflammatory cytokines production by the sigma ligand SR 31747.
    Derocq JM; Bourrié B; Ségui M; Le Fur G; Casellas P
    J Pharmacol Exp Ther; 1995 Jan; 272(1):224-30. PubMed ID: 7815336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo therapeutics of β-thujaplicin on LPS-induced inflammation in macrophages and septic shock in mice.
    Shih MF; Chen LY; Tsai PJ; Cherng JY
    Int J Immunopathol Pharmacol; 2012; 25(1):39-48. PubMed ID: 22507316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of several mediators of inflammation on the mouse hypothalamo-pituitary-adrenal axis response during acute endotoxemia.
    Hadid R; Spinedi E; Chautard T; Giacomini M; Gaillard RC
    Neuroimmunomodulation; 1999; 6(5):336-43. PubMed ID: 10474052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of post-treatment with low-dose propofol on inflammatory responses to lipopolysaccharide-induced shock in conscious rats.
    Hsu BG; Yang FL; Lee RP; Peng TC; Chen HI
    Clin Exp Pharmacol Physiol; 2005; 32(1-2):24-9. PubMed ID: 15730430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.